Publication:
Effect of the coronavirus disease 2019 pandemic on antibiotic use in primary care.

Simple item page
dc.contributor.authorPeñalva, German
dc.contributor.authorBenavente, Regina Sandra
dc.contributor.authorPerez-Moreno, Maria Antonia
dc.contributor.authorPerez-Pacheco, Maria Dolores
dc.contributor.authorPerez-Milena, Alejandro
dc.contributor.authorMurcia, Jose
dc.contributor.authorCisneros, Jose Miguel
dc.date.accessioned2023-02-09T10:41:09Z
dc.date.available2023-02-09T10:41:09Z
dc.date.issued2021-02-02
dc.description.abstractDuring the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), disruption of antimicrobial stewardship interventions has become a matter of concern. Antimicrobial resistance and the many unintended negative clinical consequences resulting from antibiotic misuse and overuse will persist and may potentially be aggravated by the pandemic , making it necessary to measure its impact on antibiotic use in all health -care settings
dc.description.versionSi
dc.identifier.citationPeñalva G, Benavente RS, Pérez-Moreno MA, Pérez-Pacheco MD, Pérez-Milena A, Murcia J, et al. Effect of the coronavirus disease 2019 pandemic on antibiotic use in primary care. Clin Microbiol Infect. 2021 Jul;27(7):1058-1060.
dc.identifier.doi10.1016/j.cmi.2021.01.021
dc.identifier.essn1469-0691
dc.identifier.pmcPMC8263053
dc.identifier.pmid33540117
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263053/pdf
dc.identifier.unpaywallURLhttp://www.clinicalmicrobiologyandinfection.com/article/S1198743X21000483/pdf
dc.identifier.urihttp://hdl.handle.net/10668/17106
dc.issue.number7
dc.journal.titleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
dc.journal.titleabbreviationClin Microbiol Infect
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
dc.organizationJaén
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number1058-1060
dc.provenanceRealizada la curación de contenido 30/04/2025
dc.publisherElsevier Ltd
dc.pubmedtypeLetter
dc.relation.publisherversionhttps://linkinghub.elsevier.com/retrieve/pii/S1198-743X(21)00048-3
dc.rightsAtribución-NoComercial-SinDerivadas 4.0 Internacional
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCOVID-19
dc.subjectCross-Sectional Studies
dc.subjectDrug Utilization
dc.subjectHumans
dc.subjectTime Factors
dc.subject.decsSARS-CoV-2
dc.subject.decsPandemias
dc.subject.decsAntibacterianos
dc.subject.decsPesos y medidas
dc.subject.decsSalud
dc.subject.decsVolición
dc.subject.decsProgramas de optimización del uso de los antimicrobianos
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshPrimary Health Care
dc.subject.meshSARS-CoV-2
dc.subject.meshSpain
dc.titleEffect of the coronavirus disease 2019 pandemic on antibiotic use in primary care.
dc.typeletter to the editor
dc.type.hasVersionVoR
dc.volume.number27
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC8263053.pdf
Size:
418.92 KB
Format:
Adobe Portable Document Format
Download

Collections

Instituto de Investigación Biomédica de Sevilla (IBIS)
SAS - D.S.A.P. Jaén
SAS - D.S.A.P. Jerez-Costa Noroeste
SAS - D.S.A.P. Sierra de Cádiz
SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía